Your browser doesn't support javascript.
loading
Safety and Effectiveness of Baricitinib in Chinese Patients with Moderate-to-Severe Rheumatoid Arthritis: 24-Week Results from a Post-Marketing Safety Study.
Wu, Chan-Yuan; Wang, Qian; Shi, Jian; Zhang, Xiu-Ying; Du, Rong; Gu, Jie-Ruo; Liu, Qi-Huan; Yu, Jiao; Xu, Jia-Wei; Zhang, Yan-Jie; Zhu, Hao; Li, Meng-Tao; Zeng, Xiao-Feng.
Afiliación
  • Wu CY; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State K
  • Wang Q; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State K
  • Shi J; Department of Rheumatology and Immunology, Yiyang Central Hospital, Central South University, Hunan, China.
  • Zhang XY; Department of Rheumatology and Immunology, Zibo Central Hospital, Shandong, China.
  • Du R; Department of Rheumatology and Immunology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China.
  • Gu JR; Department of Rheumatology and Immunology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangdong, China.
  • Liu QH; Department of Rheumatology and Immunology, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei, China.
  • Yu J; Eli Lilly and Company, Shanghai, China.
  • Xu JW; Eli Lilly and Company, Shanghai, China.
  • Zhang YJ; Eli Lilly and Company, Shanghai, China.
  • Zhu H; Eli Lilly and Company, Shanghai, China.
  • Li MT; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State K
  • Zeng XF; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology, State K
Rheumatol Ther ; 10(6): 1609-1622, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37768505
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Rheumatol Ther Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Rheumatol Ther Año: 2023 Tipo del documento: Article